These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 23118021

  • 1. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
    Oehen P, Traber R, Widmer V, Schnyder U.
    J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
    [Abstract] [Full Text] [Related]

  • 2. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
    Mithoefer MC, Mithoefer AT, Feduccia AA, Jerome L, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R.
    Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
    [Abstract] [Full Text] [Related]

  • 3. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.
    Ot'alora G M, Grigsby J, Poulter B, Van Derveer JW, Giron SG, Jerome L, Feduccia AA, Hamilton S, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R.
    J Psychopharmacol; 2018 Dec; 32(12):1295-1307. PubMed ID: 30371148
    [Abstract] [Full Text] [Related]

  • 4. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
    Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R.
    J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
    Jerome L, Feduccia AA, Wang JB, Hamilton S, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R.
    Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
    [Abstract] [Full Text] [Related]

  • 6. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
    Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R.
    Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
    [Abstract] [Full Text] [Related]

  • 7. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
    Illingworth BJ, Lewis DJ, Lambarth AT, Stocking K, Duffy JM, Jelen LA, Rucker JJ.
    J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
    [Abstract] [Full Text] [Related]

  • 8. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
    Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, Yazar-Klosinski B, Emerson A.
    Psychopharmacology (Berl); 2018 Nov; 235(11):3137-3148. PubMed ID: 30196397
    [Abstract] [Full Text] [Related]

  • 9. Narrative exposure therapy versus interpersonal psychotherapy. A pilot randomized controlled trial with Rwandan genocide orphans.
    Schaal S, Elbert T, Neuner F.
    Psychother Psychosom; 2009 Nov; 78(5):298-306. PubMed ID: 19628958
    [Abstract] [Full Text] [Related]

  • 10. Posttraumatic Growth After MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.
    Gorman I, Belser AB, Jerome L, Hennigan C, Shechet B, Hamilton S, Yazar-Klosinski B, Emerson A, Feduccia AA.
    J Trauma Stress; 2020 Apr; 33(2):161-170. PubMed ID: 32073177
    [Abstract] [Full Text] [Related]

  • 11. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
    Bouso JC, Doblin R, Farré M, Alcázar MA, Gómez-Jarabo G.
    J Psychoactive Drugs; 2008 Sep; 40(3):225-36. PubMed ID: 19004414
    [Abstract] [Full Text] [Related]

  • 12. Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
    Feduccia AA, Jerome L, Mithoefer MC, Holland J.
    Psychopharmacology (Berl); 2021 Feb; 238(2):581-588. PubMed ID: 33221932
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
    Bahji A, Forsyth A, Groll D, Hawken ER.
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan 10; 96():109735. PubMed ID: 31437480
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
    Wagner MT, Mithoefer MC, Mithoefer AT, MacAulay RK, Jerome L, Yazar-Klosinski B, Doblin R.
    J Psychopharmacol; 2017 Aug 10; 31(8):967-974. PubMed ID: 28635375
    [Abstract] [Full Text] [Related]

  • 15. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil.
    Jardim AV, Jardim DV, Chaves BR, Steglich M, Ot'alora G M, Mithoefer MC, da Silveira DX, Tófoli LF, Ribeiro S, Matthews R, Doblin R, Schenberg EE.
    Braz J Psychiatry; 2021 Aug 10; 43(2):181-185. PubMed ID: 32638920
    [Abstract] [Full Text] [Related]

  • 16. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
    Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, Wells G, Klaire SS, van der Kolk B, Tzarfaty K, Amiaz R, Worthy R, Shannon S, Woolley JD, Marta C, Gelfand Y, Hapke E, Amar S, Wallach Y, Brown R, Hamilton S, Wang JB, Coker A, Matthews R, de Boer A, Yazar-Klosinski B, Emerson A, Doblin R.
    Nat Med; 2021 Jun 10; 27(6):1025-1033. PubMed ID: 33972795
    [Abstract] [Full Text] [Related]

  • 17. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD.
    Marseille E, Kahn JG, Yazar-Klosinski B, Doblin R.
    PLoS One; 2020 Jun 10; 15(10):e0239997. PubMed ID: 33052965
    [Abstract] [Full Text] [Related]

  • 18. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
    Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R.
    J Psychopharmacol; 2013 Jan 10; 27(1):28-39. PubMed ID: 23172889
    [Abstract] [Full Text] [Related]

  • 19. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.
    Ponte L, Jerome L, Hamilton S, Mithoefer MC, Yazar-Klosinski BB, Vermetten E, Feduccia AA.
    J Trauma Stress; 2021 Aug 10; 34(4):851-863. PubMed ID: 34114250
    [Abstract] [Full Text] [Related]

  • 20. MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
    Ching TH, Williams MT, Wang JB, Jerome L, Yazar-Klosinski B, Emerson A, Doblin R.
    J Psychopharmacol; 2022 Aug 10; 36(8):974-986. PubMed ID: 35727042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.